Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,919.99
(
0.90%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GrthzGd

Send PM Follow Ignore
Followers 15
Posts 1612
Boards Moderated 1
Alias Born 09/07/2010

GrthzGd

Re: zipjet post# 188255

Friday, 03/06/2015 9:39:07 AM

Friday, March 06, 2015 9:39:07 AM

Post# of 257302
DD's interpretation very much accords with my recollection. Luly mentioned only ICPT (and favorably) when discussing the competitive landscape. I tried to draw him out on my pet NASH company Genfit which unlike ICPT, targets the peroxisome proliferator-activated receptor (PPAR)-a/d. I drew a complete blank.

Funny, I had originally bought ICPT as a hedge against GNFT.PA (before selling it last summer); now all I have to do is hang on to ENTA!

"The curious task of economics is to demonstrate to men how little they really know about what they imagine they can design." -F.A. von Hayek

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today